Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Endometriosis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    85 result(s) found for: Endometriosis. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2015-000644-42 Sponsor Protocol Number: 52456 Start Date*: 2016-01-04
    Sponsor Name:VU University medical center (VUmc)
    Full Title: Laparoscopic advanced Imaging Techniques in Endometriosis therapy: LITE-study. A pilot trial.
    Medical condition: Endometriosis
    Disease: Version SOC Term Classification Code Term Level
    18.1 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-008722-73 Sponsor Protocol Number: PPP/2008 Start Date*: 2009-04-20
    Sponsor Name:AZIENDA OSPEDALIERA PISANA
    Full Title: ROLE OF PAROXETINE AS ADD-ON THERAPY TO GNRH AGONIST IN THE TREATMENT OF ENDOMETRIOSIS-RELATED CHRONIC PELVIC PAIN
    Medical condition: Endometriosis-associated pelvic pain
    Disease: Version SOC Term Classification Code Term Level
    9.1 10014778 Endometriosis LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2022-002424-12 Sponsor Protocol Number: KETA-TEAM Start Date*: 2022-11-17
    Sponsor Name:Médipôle Hôpital Mutualiste
    Full Title: KETA-TEAM A Phase 2 Study to Assess the Safety and Efficacy of Ketamine, Treatment for Endometriosis-related chronic pain as Analgesic in Médipôle
    Medical condition: Endometriosis with refractory chronic pelvic pain
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005744-17 Sponsor Protocol Number: ENDOMET-IA-DIULNG08 Start Date*: 2008-11-10
    Sponsor Name:PEDRO ACIEN ALVAREZ
    Full Title: INHIBIDORES DE LA AROMATASA (ANASTROZOL) ASOCIADOS A DISPOSITIVO INTRAUTERINO LIBERADOR DE LEVONORGESTREL (DIU-LNG) EN EL TRATAMIENTO DE LA ENDOMETRIOSIS MODERADA/SEVERA
    Medical condition: ENDOMETRIOSIS MODERADA/SEVERA
    Disease: Version SOC Term Classification Code Term Level
    9 10014778 Endometriosis LLT
    9 10014784 Endometriosis of ovary LLT
    9 10014788 Endometriosis related pain LLT
    9 10014785 Endometriosis of pelvic peritoneum LLT
    9 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2022-001810-21 Sponsor Protocol Number: 2022-001810-21 Start Date*: 2022-08-23
    Sponsor Name:Aarhus University Hospital, Department of Anaesthesiology
    Full Title: Intraoperative clonidine for postoperative pain management in patients undergoing surgical treatment for endometriosis: a prospective, double-blind, randomized controlled trial
    Medical condition: Endometriosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-004361-40 Sponsor Protocol Number: 2013/CHU/12 Start Date*: 2020-12-18
    Sponsor Name:CHU de la Réunion
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2013-000993-32 Sponsor Protocol Number: S55300 Start Date*: 2013-05-07
    Sponsor Name:University Hospital Leuven
    Full Title: Does prolonged GnRH downregulation prior to ART improve the clinical pregnancy rate in postoperative endometriosis patients? A RCT
    Medical condition: endometriosis, subfertility
    Disease: Version SOC Term Classification Code Term Level
    15.1 100000004872 10042392 Subfertility (female) LLT
    15.1 100000004872 10014789 Endometriosis, site unspecified LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2022-000652-11 Sponsor Protocol Number: SPAGOPIX-02 Start Date*: 2022-08-17
    Sponsor Name:Spago Nanomedical AB
    Full Title: A Phase IIa, single centre, open label, proof of concept study concerning efficacy of the novel intravenous contrast agent SN132D in patients with suspected endometriosis.
    Medical condition: Suspected endometriosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2013-005494-53 Sponsor Protocol Number: Start Date*: 2014-10-16
    Sponsor Name:Norfolk and Norwich University Hospitals NHS Foundation Trust
    Full Title: A Study of the Histopathological Changes within Ectopic Endometrial Tissue, in Subjects with Known Pelvic Endometriosis Following Treatment with Ulipristal Acetate, a Selective Progesterone Recepto...
    Medical condition: Endometriosis
    Disease: Version SOC Term Classification Code Term Level
    17.0 10042613 - Surgical and medical procedures 10057902 Endometriosis ablation PT
    17.0 10038604 - Reproductive system and breast disorders 10014785 Endometriosis of pelvic peritoneum LLT
    17.0 10038604 - Reproductive system and breast disorders 10014788 Endometriosis related pain LLT
    17.0 10042613 - Surgical and medical procedures 10014779 Endometriosis in pelvis, excision LLT
    17.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2009-017169-53 Sponsor Protocol Number: BAY86-5258/13788 Start Date*: 2011-01-17
    Sponsor Name:Bayer HelathCare AG
    Full Title: Estudio multicéntrico, abierto, de un brazo de tratamiento para evaluar la seguridad y la eficacia de la administración oral diaria de 2 mg de Dienogest en el tratamiento de la endometriosis en ado...
    Medical condition: Sospecha clínica o confirmada de endometriosis en mujeres adolescentes post-menarquia de 12 a menos de 18 años de edad (Clinically suspected or confirmed endometriosis in post menarche female adole...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10014778 Endometriosis LLT
    Population Age: Adolescents, Under 18 Gender: Female
    Trial protocol: ES (Completed) FI (Completed) DE (Completed) AT (Completed) FR (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2017-000244-18 Sponsor Protocol Number: BAY1128688/17472 Start Date*: 2017-09-25
    Sponsor Name:Bayer AG
    Full Title: A randomized, placebo-controlled, double-blind, parallel-group, multi-center, exploratory dose-response study to assess the efficacy and safety of different oral doses of BAY 1128688 in women with ...
    Medical condition: Endometriosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10014788 Endometriosis related pain LLT
    20.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Prematurely Ended) ES (Prematurely Ended) HU (Prematurely Ended) FI (Prematurely Ended) CZ (Prematurely Ended) AT (Prematurely Ended) DE (Prematurely Ended) BE (Prematurely Ended) DK (Prematurely Ended) NL (Prematurely Ended) PL (Prematurely Ended) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-005167-24 Sponsor Protocol Number: PGL11-007 Start Date*: 2012-05-04
    Sponsor Name:PregLem S.A.
    Full Title: A Phase II, Multicentre, Randomised, Two-Arm, Parallel Group, Double-Blind, Placebo controlled Study of the Steroid Sulfatase Inhibitor PGL2001 with concomitant administration of NETA (norethistero...
    Medical condition: Treatment of symptoms related to endometriosis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: HU (Completed) PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-003829-28 Sponsor Protocol Number: TAK-013/EC204 Start Date*: 2004-12-22
    Sponsor Name:Takeda Europe R&D Centre Ltd
    Full Title: An open-label investigation into the tolerability and pharmacokinetic / pharmacodynamic effects of sufugolix (TAK-013), at a dosage of 100mg twice-daily, during six months treatment of pre-menopaus...
    Medical condition: symptomatic endometriosis
    Disease: Version SOC Term Classification Code Term Level
    7 10014778 LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed) DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-001984-21 Sponsor Protocol Number: 3/013/13 Start Date*: 2013-09-11
    Sponsor Name:University of Aberdeen & NHS Grampian
    Full Title: PRE-EMPT: Preventing Recurrence of Endometriosis by Means of long acting Protestogen Therapy
    Medical condition: Endometriosis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2017-005022-38 Sponsor Protocol Number: T366/2017 Start Date*: 2018-06-13
    Sponsor Name:Turku University Hospital
    Full Title: Oxytocin in mr guided focused ultrasound treatment (MRI-HIFU)
    Medical condition: women with uterine fibroids or adenomyosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004864 10016628 Fibroids LLT
    20.0 10038604 - Reproductive system and breast disorders 10056268 Adenomyosis PT
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-000915-26 Sponsor Protocol Number: 000295 Start Date*: 2019-05-10
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, double-blind, placebo-controlled, proof-of-mechanism phase 2 trial investigating the effect of quinagolide extended-release vaginal ring on reduction of lesions assessed by high-resol...
    Medical condition: Deep infiltrating endometriosis, endometrioma and/or adenomyosis.
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004872 10014787 Endometriosis of uterus LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) DK (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2012-001219-22 Sponsor Protocol Number: PGL11-021 Start Date*: 2012-06-11
    Sponsor Name:PregLem S.A.
    Full Title: A Phase IIa study investigating the efficacy and safety of the c-Jun-N-Terminal Kinase (JNK) inhibitor PGL5001 versus placebo administered for up to 5 months with concomitant administration of depo...
    Medical condition: Peritoneal and/or ovarian endometriosis with an inflammatory component.
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004872 10014784 Endometriosis of ovary LLT
    14.1 100000004872 10014785 Endometriosis of pelvic peritoneum LLT
    Population Age: Adults Gender: Female
    Trial protocol: PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-004768-72 Sponsor Protocol Number: BAY1002670/15792 Start Date*: 2018-06-11
    Sponsor Name:Bayer AG
    Full Title: A randomized, double-blind, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of two different doses of vilaprisan (BAY 1002670) versus placebo in women with symptomatic ...
    Medical condition: Pre-menopausal women 18 years and older with confirmed endometriosis and moderate to severe endometriosis-associated pelvic pain (EAPP), otherwise in good general health.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: AT (Completed) FI (Completed) DK (Prematurely Ended) SE (Prematurely Ended) ES (Prematurely Ended) DE (Prematurely Ended) HU (Completed) BG (Prematurely Ended) CZ (Prematurely Ended) PL (Prematurely Ended) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-002991-15 Sponsor Protocol Number: ABR41273 Start Date*: 2013-04-03
    Sponsor Name:
    Full Title: MR-imaging to diagnose endometriosis using Ablavar ® as contrast agent – a feasibility study’
    Medical condition: endometriosis
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-001721-13 Sponsor Protocol Number: TAK-013/EC-302 Start Date*: 2005-01-24
    Sponsor Name:Takeda Europe R&D Center Ltd
    Full Title: A Phase III, multi-center, randomized, double-blind study to evaluate the efficacy and safety of 50 mg and 100 mg of sufugolix (TAK-013) tablets administered twice daily versus placebo for 12 weeks...
    Medical condition: Endometriosis
    Disease: Version SOC Term Classification Code Term Level
    7 10014778 LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue May 06 09:50:19 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA